Upregulation of cystathione β‐synthase and p70S6K/S6 in neonatal hypoxic ischemic brain injury

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Brain Pathology

• Publication date

  2017-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bpa.12421PMID 27465493PMCID PMC8028969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysregulation of FMRP/mTOR Signaling Cascade in Hypoxic-Ischemic Injury of Premature Human Brain

  2016cited by this paper
• Persistent Angiogenesis in the Autism Brain: An Immunocytochemical Study of Postmortem Cortex, Brainstem and Cerebellum

  2015cited by this paper
• Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.

  2015cited by this paper
• Ultrastructural Correlates of Enhanced Norepinephrine and Neuropeptide Y Cotransmission in the Spontaneously Hypertensive Rat Brain

  2015cited by this paper
• Cystathionine β-Synthase Inhibition Is a Potential Therapeutic Approach to Treatment of Ischemic Injury

  2015cited by this paper
• Preliminary findings suggest the number and volume of supragranular and infragranular pyramidal neurons are similar in the anterior superior temporal area of control subjects and subjects with autism.

  2015cited by this paper
• Increased Brain Perfusion Persists over the First Month of Life in Term Asphyxiated Newborns Treated with Hypothermia: Does it Reflect Activated Angiogenesis?

  2015cited by this paper
• Role of hydrogen sulfide in secondary neuronal injury.

  2014cited by this paper
• mTOR signaling and its roles in normal and abnormal brain development

  2014cited by this paper
• Bacterial gasotransmitters: an innate defense against antibiotics.

  2014cited by this paper
• Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

  2013cited by this paper
• Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.

  2013cited by this paper
• Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation

  2012cited by this paper
• H2S Protects Hippocampal Neurons from Anoxia–Reoxygenation Through cAMP-Mediated PI3K/Akt/p70S6K Cell-Survival Signaling Pathways

  2011influential reference
• Toxicological screening

  2011cited by this paper
• Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism.

  2011influential reference
• Automated quantitative gait analysis in animal models of movement disorders

  2010cited by this paper
• mTOR signaling: at the crossroads of plasticity, memory and disease.

  2010cited by this paper
• Electro-acupuncture protects against hypoxic-ischemic brain-damaged immature rat via hydrogen sulfide as a possible mediator.

  2010cited by this paper
• Hypoxia-inducible factor-1α is involved in the pro-angiogenic effect of hydrogen sulfide under hypoxic stress.

  2010influential reference
• Anxiety in children and adolescents with autism spectrum disorders.

  2009cited by this paper
• Mouse Models of Fragile X-Associated Tremor Ataxia

  2009cited by this paper
• The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.

  2009influential reference
• Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia

  2008cited by this paper
• Hypoxia-inducible Factor 1α Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif*

  2007cited by this paper
• Hydrogen sulphide and its therapeutic potential

  2007cited by this paper
• High Plasma Cyst(e)ine Level May Indicate Poor Clinical Outcome in Patients With Acute Stroke: Possible Involvement of Hydrogen Sulfide

  2006influential reference
• Hydrogen Sulfide Is a Mediator of Cerebral Ischemic Damage

  2006influential reference
• Designing mouse behavioral tasks relevant to autistic-like behaviors.

  2004influential reference
• Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice

  2004influential reference
• Nitrosative and Oxidative Injury to Premyelinating Oligodendrocytes in Periventricular Leukomalacia

  2003influential reference
• Angiogenesis in the central nervous system: a role for vascular endothelial growth factor/vascular permeability factor and tenascin-C. Common molecular effectors in cerebral neoplastic and non-neoplastic "angiogenic diseases".

  2002cited by this paper
• Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor.

  2000influential reference
• Combination of open field and elevated plus-maze: a suitable test battery to assess strain as well as treatment differences in rat behavior.

  1998cited by this paper
• Brain ischemia markedly elevates levels of the neurotoxic amino acid, cysteine.

  1993cited by this paper

• Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)

  2025cites this paper
• Activation of AHR by ITE improves cardiac remodelling and function in rats after myocardial infarction

  2023cites this paper
• Pleiotrophin ameliorates white matter injury of neonatal rats by activating the mTOR/YY1/Id4 signaling pathway

  2023cites this paper
• Cerebroprotective actions of hydrogen sulfide in the epileptic brain in newborn pigs

  2023cites this paper
• Physiological roles of hydrogen sulfide in mammalian cells, tissues and organs.

  2022cites this paper
• FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders

  2022cites this paper
• Cystathionine beta-Synthase in hypoxia and ischemia/reperfusion: A current overview.

  2022cites this paper
• Genetics and Epigenetics of One-Carbon Metabolism Pathway in Autism Spectrum Disorder: A Sex-Specific Brain Epigenome?

  2021cites this paper
• Exposure to DMSO during infancy alters neurochemistry, social interactions, and brain morphology in long‐evans rats

  2021cites this paper
• A Pro-social Pill? The Potential of Pharmacological Treatments to Improve Social Outcomes After Pediatric Traumatic Brain Injury

  2021cites this paper
• Moderately Inducing Autophagy Reduces Tertiary Brain Injury after Perinatal Hypoxia-Ischemia

  2020cites this paper
• Angelica polysaccharide moderates hypoxia-evoked apoptosis and autophagy in rat neural stem cells by downregulation of BNIP3

  2019cites this paper
• Nitric oxide acutely modulates hypothalamic and neurohypophyseal carbon monoxide and hydrogen sulphide production to control vasopressin, oxytocin and atrial natriuretic peptide release in rats

  2019cites this paper
• Induction and Assessment of Hypoxia in Glioblastoma Cells In Vitro.

  2018cites this paper
• Cognitive Impairment and Brain and Peripheral Alterations in a Murine Model of Intraventricular Hemorrhage in the Preterm Newborn

  2017cites this paper
• Age-Dependent Effects of ALK5 Inhibition and Mechanism of Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury

  2017cites this paper
• A Controversial Medicolegal Issue: Timing the Onset of Perinatal Hypoxic-Ischemic Brain Injury

  2017cites this paper